Scalable Inhibitors of the Nsp3–Nsp4 Coupling in SARS-CoV-2-Reference-Cited by-同舟云学术

Scalable Inhibitors of the Nsp3–Nsp4 Coupling in SARS-CoV-2

Published:2023-02-06 Issue:6 Volume:8 Page:5349-5360
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Azizogli Abdul-Rahman¹,Pai Varun¹,Coppola Francesco²^ORCID,Jafari Roya²,Dodd-o Joseph B.³,Harish Rohan⁴,Balasubramanian Bhavani⁵,Kashyap Jatin³,Acevedo-Jake Amanda M.³,Král Petr²⁶^ORCID,Kumar Vivek A.¹³⁷⁸^ORCID

Affiliation:

1. Department of Biological Sciences, New Jersey Institute of Technology, Newark, New Jersey 07102, United States

2. Department of Chemistry, University of Illinois at Chicago, Chicago, Illinois 60607, United States

3. Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States

4. Department of Electrical and Computer Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States

5. Department of Chemistry and Environmental Sciences, New Jersey Institute of Technology, Newark, New Jersey 07102, United States

6. Departments of Physics, Pharmaceutical Sciences, and Chemical Engineering, University of Illinois at Chicago, Chicago, Illinois 60607, United States

7. Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States

8. Department of Endodontics, Rutgers School of Dental Medicine, Newark, New Jersey 07103, United States

Funder

National Center for Advancing Translational Sciences

National Eye Institute

Division of Industrial Innovation and Partnerships

National Institute of Dental and Craniofacial Research

Nanjing Institute of Technology

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c06384

Reference84 articles.

1. A new coronavirus associated with human respiratory disease in China

2. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

3. WHO. Coronavirus Disease (COVID-19) Dashboard, 2022. https://covid19.who.int/.

4. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

5. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Paxlovid on in-hospital outcomes and post-COVID-19 condition in adult patients infected with SARS-CoV-2 Omicron variant: A non-randomized controlled clinical trial;Medicine;2023-12-22

2. CoVEx: SARS-CoV-2 Mutation Explorer for genomic surveillance;Infection, Genetics and Evolution;2023-12

3. Engineered Therapeutic Antibody Against SARS-CoV-2;Current Clinical Microbiology Reports;2023-11-14